Canaccord Genuity gives a Hold recommendation for Veracyte Inc (VCYT)

Samantha Gray

Veracyte Inc’s recently made public that its Director Holstein Jens unloaded Company’s shares for reported $0.42 million on Nov 20 ’25. In the deal valued at $42.36 per share,10,000 shares were sold. As a result of this transaction, Holstein Jens now holds 27,199 shares worth roughly $1.27 million.

Then, JENS HOLSTEIN bought 10,000 shares, generating $423,563 in total proceeds.

Before that, Wygant Jonathan sold 5,818 shares. Veracyte Inc shares valued at $233,929 were divested by the VP, Chief Accounting Officer at a price of $40.21 per share. As a result of the transaction, Wygant Jonathan now holds 43,847 shares, worth roughly $2.05 million.

Canaccord Genuity initiated its Veracyte Inc [VCYT] rating to a Hold in a research note published on October 20, 2025; the price target was $40. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Goldman also remained covering VCYT and has decreased its forecast on December 05, 2024 with a “Neutral” recommendation from previously “Buy” rating. Wolfe Research started covering the stock on November 15, 2024. It rated VCYT as “an Outperform”.

Price Performance Review of VCYT

On Monday, Veracyte Inc [NASDAQ:VCYT] saw its stock jump 6.11% to $46.7. Over the last five days, the stock has gained 18.89%. Veracyte Inc shares have risen nearly 19.13% since the year began. Nevertheless, the stocks have risen 17.93% over the past one year. While a 52-week high of $47.32 was reached on 01/30/25, a 52-week low of $22.61 was recorded on 07/18/25.

Levels Of Support And Resistance For VCYT Stock

The 24-hour chart illustrates a support level at 44.32, which if violated will result in even more drops to 41.93. On the upside, there is a resistance level at 48.01. A further resistance level may holdings at 49.31.

How much short interest is there in Veracyte Inc?

A steep rise in short interest was recorded in Veracyte Inc stocks on 2025-10-31, dropping by -1.29 million shares to a total of 6.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 7.33 million shares. There was a decline of -21.3%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on October 16, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.